SUMMARY We describe a patient with rheumatoid arthritis and widespread joint and periarticular calcinosis related to self-medication with vitamin D, which was aggravated by oral phosphate therapy prescribed for her hypercalcaemia. Hydroxyapatite was shown in the synovial fluid from affected joints. The role played by tissue injury in the pathogenesis of soft tissue calcification is discussed.
Soft tissue calcification is commonly seen in connective tissue diseases such as scleroderma or in patients with hypercalcaemia or hyperphosphataemia. Larger periarticular deposits of calcium are seen in tumoral calcinosis, a familial disease common in Negroes, which is often associated with hyperphosphataemia.1 Similar large deposits have been described in patients with chronic renal failure treated with haemodialysis,2 in the milk-alkali syndrome,3 and in vitamin D intoxication.4
We report a patient with rheumatoid arthritis who developed chronic renal failure and extensive calcified swellings in periarticular soft tissues after selfmedication with cod liver oil. She had no episodes of acute arthritis and the carbonated apatite crystals identified in the swellings were relatively noninflammatory in laboratory tests, possibly as a result of surface coating.
Case report
A 48-year-old woman developed a symmetrical polyarthritis with typical rheumatoid erosions. She was treated with non-steroidal anti-inflammatory drugs, and between 1970 and 1975 with prednisolone, but her arthritis was progressive, and she Accepted for publication 1 February 1985. Correspondence to Dr R C Butler (Fig. 3a) . Plasma calcium was normal, but phosphate and urea were raised. Her mobility was greatly inhibited by generalised joint pains. Aspiration of the left wrist joint and of the swelling in the right groin showed bloodstained creamy fluid. The fluid was examined by light and electron microscopy. The predominant solid phase consisted of irregular, non-birefringent spherulites varying from 0*1 to 5 im in diameter. On infrared spectrophotometry the typical pattern of hydroxyapatite was obtained, with small absorption peaks indicative of carbonate substitution (Fig. 4) .
Strong protein bands were also present, but the type of protein associated with the mineral was not identified. Surface charge of the particles was assessed electrophoretically and found to be relatively low (patient's mineral particles 0-4 [tmlslV;
standard hydroxyapatite crystals 0-78 RmlsfV). The inflammatory potential of the material was assessed by injections into the rat foot pad. The swelling produced was much less than that of an equal weight of pure, laboratory made hydroxyapatite (data not presented).
In view of her immobility she was treated with prednisolone 15 mg daily with marked symptomatic improvement and a fall in plasma calcium, and she was discharged from hospital. One month later she developed severe abdominal pain due to perforation of a duodenal ulcer, which was oversewn. After the operation oral phosphate was discontinued, her prednisolone was reduced to 5 mg daily, and she was started on long-term cimetidine. The swellings decreased in size and by early January 1983 had disappeared, even though her plasma calcium was raised during this period. Between February and April it was maintained within the normal range on 4-5 mg prednisolone daily, but when the dose of prednisolone was reduced her plasma calcium increased, only to fall again after a modest increase in dose from 1 mg to 3 mg daily (see Fig. 1 ). There has been no recurrence of the swellings, and x-rays no longer show calcinosis (Fig. 3b ). Fig. 3 (a) Extensive periarticular soft tissue calcification in left hand 11 months after initiation ofphosphate therapy, which is no longer seen in (b) the x-ray taken 22 months after phosphate had been discontinued and oral prednisolone started.
phosphate products, and in the present case striking accumulations of calcified material were confined to previously damaged joints and overlying skin. This distribution resembles that reported by Holman4 in eight patients with hypervitaminosis D who also had rheumatoid arthritis or gout: no such deposits were seen in a further 48 patients with hypervitaminosis D who did not have chronic arthritis. These eight patients resembled the present case in the degree of hypercalcaemia, of hyperphosphataemia, and of renal failure; four had taken vitamin D for a similar period of time, the remainder for between three and 14 years. As Holman pointed out, although dam 
